Clinical Trial Update: A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1 [Phase 1]

View source ↗

Summary

A Phase 1b study of PPI-461 in patients with chronic genotype 1 hepatitis C virus infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PPI-461

Snippet

Sponsor: Presidio Pharmaceuticals, Inc. | Conditions: Chronic Genotype 1 Hepatitis C Virus Infection | Phase 1 | Status: COMPLETED